Oxford, United Kingdom

Stephen Hyde

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 2.8

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2014-2022

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Stephen Hyde

Introduction

Stephen Hyde is a notable inventor based in Oxford, GB. He has made significant contributions to the field of gene therapy and molecular biology, holding a total of 3 patents. His work focuses on developing advanced nucleic acid constructs and lentiviral vectors that have the potential to revolutionize treatments for various diseases.

Latest Patents

Hyde's latest patents include a groundbreaking nucleic acid construct designed for high-level and sustained gene expression. This construct features a hCEF1 promoter that is operably linked to a sequence for expression, which can be utilized for gene expression of selected sequences. The hCEF1 promoter comprises a human CMV enhancer linked to a human EFI a promoter, along with functional fragments and variants. Another significant patent involves lentiviral vectors that are pseudotyped with hemagglutinin-neuraminidase (HN) and fusion (F) proteins from a respiratory paramyxovirus. These vectors are designed for gene transfer and have applications in gene therapy, particularly for treating respiratory tract diseases such as Cystic Fibrosis (CF).

Career Highlights

Throughout his career, Stephen Hyde has worked with various innovative companies, including Ip2ipo Innovations Limited and Isis Innovation Limited. His expertise in gene therapy and molecular biology has positioned him as a key figure in the development of new therapeutic strategies.

Collaborations

Hyde has collaborated with esteemed colleagues in his field, including Deborah Gill and Eric Walter Frederick Wolfgang Alton. These partnerships have further enhanced his research and contributions to the scientific community.

Conclusion

Stephen Hyde's innovative work in gene therapy and molecular biology has led to significant advancements in the treatment of respiratory diseases. His patents reflect a commitment to improving healthcare through scientific innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…